Technologies

time icon Oct. 16, 2012

Compounds to treat diabetic complications

Technology description

Prevention of diabetes and its complications are an increasing focus of public health efforts. One of the key problems is that few treatments for diabetes other than insulin are effective, and there is little that can be done to treat complications arising from diabetes.

Investigators at the Weill Medical College of Cornell University and SUNY have found that elevated glucose levels scavenge NO and cause premature vascular senescence, leading directly to complications such as diabetic retinopathy and other vasculopathies.

The investigators have demonstrated a direct NO-scavenging capacity of D-glucose. Thus rapid chemical inactivation of NO by glucose may be an important contributor to the dampened NO bioactivity observed in blood vessels from diabetic patients. They have also demonstrated both in vitro and in vivo that the vascular endothelium becomes prematurely senescent in the presence of elevated levels of glucose and advanced glycation end-products (AGEs) of proteins.

Application area

Methods to treat disorders associated with elevated levels of glucose and AGEs, which include chronic renal disease, end stage renal disease, poorly controlled diabetes mellitus, systemic lupus erythernatosus, and Alzheimer's disease and other neurodegenerative diseases.

由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。

More information

Institution
Categories
  • Diagnosis and treatment
  • Endocrinology
Keywords:

public health efforts

weill medical college

direct no-scavenging capacity

rapid chemical inactivation

advanced glycation end-products

下载 PDF 文档


感兴趣

Contact us

知繁业茂-yintrust logo知繁业茂-Branchly Innovation logo 知繁业茂-autmasia logo迈科技 logo